5α-Reductase Isozymes in the Central Nervous System
Steroids, ISSN: 0039-128X, Vol: 63, Issue: 5, Page: 246-251
1998
- 90Citations
- 32Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations90
- Citation Indexes90
- 90
- CrossRef67
- Captures32
- Readers32
- 32
Article Description
The enzyme 5α-reductase (5α-R) activates several Δ4–3keto steroids to more potent derivatives which may also acquire new biological actions. Testosterone gives rise to the most potent natural androgen dihydrotestosterone (DHT), and progesterone to dihydroprogesterone (DHP), a precursor of the endogenous anxiolytic/anesthetic steroid tetrahydroprogesterone (THP). Two isoforms of 5α-R, with a limited degree of homology, different biochemical properties and distinct tissue distribution have been cloned: 5α-R type 1 and type 2. In androgen-dependent structures DHT is almost exclusively formed by 5α-R type 2; 5α-R type 1 is widely distributed in the body, with the highest levels in the liver, and may be involved in steroid catabolism. In the brain, the roles of the two isozymes are still largely unknown. This brief review will summarize recent experimental data from our laboratory which try to assign possible functional roles to the process of 5α-reduction, and to the two 5α-R isoforms in the CNS.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0039128X9800018X; http://dx.doi.org/10.1016/s0039-128x(98)00018-x; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0032076187&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/9618779; https://linkinghub.elsevier.com/retrieve/pii/S0039128X9800018X; http://dx.doi.org/10.1016/s0039-128x%2898%2900018-x; https://dx.doi.org/10.1016/s0039-128x%2898%2900018-x
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know